Expression and subcellular localization of RAGE in melanoma cells

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• The receptor for advanced glycation end products (RAGE) plays a role in tumor development and malignancy.
• Understanding RAGE's function in tumor progression requires investigating its expression and localization in melanoma cells.

Purpose of the Study:

• To investigate the expression profile and subcellular localization of RAGE in melanoma cells at different malignancy stages.
• To determine the impact of RAGE localization and oligomerization on melanoma cell migration and progression.

Main Methods:

• Immunofluorescence microscopy to visualize RAGE localization in melanoma cells.
• RNA interference (RNAi) to silence RAGE expression and assess its effect on cell migration.
• Western blot analysis and SDS-PAGE to study RAGE oligomerization and glycosylation.
• Treatment with cholesterol-chelating drugs (nystatin, filipin) to investigate RAGE's association with cholesterol-rich membranes.

Main Results:

• RAGE localized to membrane ruffles and leading edges in primary melanoma cells (MelJuSo), but was more dispersed in metastatic cells (SK-Mel28).
• RAGE silencing inhibited MelJuSo cell migration but not SK-Mel28 cell migration.
• MelJuSo cells exhibited more complex RAGE oligomerization compared to melanocytes and SK-Mel28 cells, involving disulfide bonds and other interactions.
• Cholesterol-chelating drugs altered RAGE localization in MelJuSo cells; SK-Mel28 cells showed reduced RAGE glycosylation, cholesterol association, and soluble forms.

Conclusions:

• RAGE isoform expression and subcellular localization are critical regulators of its function in melanoma progression.
• Distinct RAGE localization and oligomerization patterns correlate with melanoma cell malignancy and migratory potential.
• RAGE's interaction with cholesterol-rich membranes influences its function in melanoma cells.